Schedule 13G ownership disclosure

Coya Therapeutics Inc

Common Stock, $0.0001 par value per share · CUSIP: 22407B108

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Orin Hirschman

    Shares: 1,333,919.00 · Class: 8%

  • AIGH Capital Management LLC

    Shares: 1,201,152.00 · Class: 7.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-005549
Form type
SCHEDULE 13G/A
Filer
Coya Therapeutics, Inc.
CIK
CIK 1835022
Filed
Feb 10, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub